{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-23-249206","form_type":"8-K","ticker":"VTRS","cik":"0001792044","company_name":"Viatris Inc","filed_at":"2023-10-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:30.471260+00:00","generated_at":"2026-06-10T06:27:46.878360+00:00","sec_items":["1.01"],"event_type":"m_and_a","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Viatris enters agreement to sell OTC business to Cooper Consumer Health for up to €1.95B","bullets":["Up to €1.95B cash consideration: €1.85B at closing plus up to €100M contingent on return multiple.","Option exercisable by Viatris after employee consultations; expires Feb 2, 2024.","Closing subject to regulatory approvals from EU Commission, Serbia, France, and Italy.","Viatris to provide transition services; €25M advance payment at closing for TSA fees.","€120M of consideration retained by buyer for future sale of select geographies."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-23-249206","json":"https://secwatch.observer/filing/0001193125-23-249206.json","markdown":"https://secwatch.observer/filing/0001193125-23-249206.md","text":"https://secwatch.observer/filing/0001193125-23-249206.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/0001193125-23-249206-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/d470098d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-10T06:27:46.878360+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"95b5c6f27accac0e3b80fac35857a5847e8db1b9","claim":"Viatris Inc entered into Transaction Agreement with Cooper Consumer Health SAS valued at up to €1,950.0 million (effective 2023-10-01).","evidence_excerpt":"On October 1,2023, Viatris Inc., a Delaware corporation (“ Viatris ” or the “ Company ”) entered into an agreement with Cooper Consumer Health SAS, a French corporation (“ Buyer Parent ”) pursuant to which Buyer Parent made a binding offer (“ the Offer ”), by irrevocably granting Viatris an option (the “ Option ”), to require the Buyer Parent and certain of its affiliates (collectively, the “ Buyer Parties ”) to purchase and assume, as applicable, substantially all of Viatris’ over-the-counter products business (the “ Business ”) and related assets and liabilities, on the terms and subject to the conditions of a negotiated form of Transaction Agreement described below (such form, the “ Transaction Agreement ” and such potential transaction, the “ Transaction ”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1792044/000119312523249206/0001193125-23-249206-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"asset purchase"},{"label":"Counterparty","value":"Cooper Consumer Health SAS"},{"label":"Value","value":"up to €1,950.0 million"},{"label":"Effective","value":"2023-10-01"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}